During the initial height of the pandemic in 2020, the documented incidence of end-stage kidney disease, defined as initiation of maintenance dialysis or receipt of a preemptive kidney transplant, decreased compared with corresponding periods during 2017-2019.
This study supports the role of the dialysis facility as a systems-level barrier in referral for kidney transplantation, according to investigators.
Among children on dialysis, those with lupus nephritis were more likely to be hospitalized.
Full results from the OPTIMIZE study, due to be completed in August 2021, are forthcoming.
Investigators reviewed 13 trials of spironolactone and 1 trial of eplerenone.
Older adults and individuals with diabetes did not experience a faster decline in SARS-CoV-2 antibody titers, investigators found.
Routine pain assessments using validated scales are vital to develop personalized management strategies, according to investigators.
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
During weeks 12-19 of 2020, the incidence of end-stage kidney disease decreased 20% compared with the same period in 2017-2019, according to a COVID-19 supplement to the US Renal Data System 2020 annual data report.
Patients with multiple myeloma on dialysis who are undergoing autologous stem cell transplantation are at an increased risk for inpatient mortality.